"Everyone faced with limb length discrepancy (LLD), especially pediatric patients, should have access to a non-invasive limb lengthening solution," said
Precice is a magnetically adjustable technology that utilizes an external remote to non-invasively lengthen implants. The Precice nail has been implanted more than 15,000 times, by more than 2,000 surgeons, and in nearly 50 countries. As a division of
"Precice has over a decade's worth of clinical data and has truly changed the standard of care for my patients," said Dr.
Furthering the Company's ability to treat the full continuum of care, the next phase of NSO's orthopedic innovation is intelligent surgery. The Company's asset acquisition efforts in
*The Precice IMLL System is indicated for limb lengthening of the femur and tibia in pediatric patients (greater than 12 years old).
1. Richardson, S, Schairer W, Fragomen A, et al. Cost Comparison of Femoral Distraction Osteogenesis With External Lengthening Over a Nail Versus Internal Magnetic Lengthening Nail. J Am Acad Orthop Surg 2019
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-specialized-orthopedics-expands-indications-of-precice-limb-lengthening-system-to-treat-pediatric-patients-301775389.html
Investor contact: Juliet C. Cunningham, NuVasive, Inc., 858-210-2129, email@example.com; Media contact: Melanie Ordoñez, NuVasive, Inc., 858-722-3899, firstname.lastname@example.org